VUMC News and Communications
-
November 15, 2018
Cancer research trailblazer
Stephen B. Baylin, MD, a leading cancer researcher from the Johns Hopkins School of Medicine, described his trailblazing studies of cancer epigenetics last week during a Flexner Discovery Lecture. -
November 8, 2018
Evading cell death
Stress granules that form in response to cellular stress help cancer cells survive and develop resistance to treatment. -
November 8, 2018
Vitamin C protects brain from seizures
Brain ascorbate — vitamin C — is important for protecting the brain against seizures and cognitive decline in Alzheimer’s disease. -
November 8, 2018
Novel methods to treat glaucoma
Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease. -
November 8, 2018
Obesity negates beneficial drug effects
A drug that improves levels of “good” cholesterol may not be beneficial for obese individuals, Vanderbilt researchers have discovered. -
November 8, 2018
Diabetes Day 2018
Outstanding research achievement was recognized during last week’s Diabetes Day at the Vanderbilt Student Life Center.